Greater Manchester Cancer Alliance - Acute Oncology Transformation
The Greater Manchester Cancer Alliance
The Greater Manchester Cancer Alliance brings together clinical and managerial leaders from all hospital trusts and other health and care organisations across the entire region, alongside user involvement representatives and other partners. Working in partnership enables care to be effectively planned across all parts of our cancer pathways. By bringing together world-class researchers, clinicians and operational delivery, they have a unique opportunity to improve the lives of people affected by cancer in their region.
Find out more about the cancer alliance >>>
The Greater Manchester Cancer Alliance (GMCA) team have kindly shared some information about the transformation work that has been undertaken across the alliance footprint.
The Alliance has committed to a 5-year AO transformation strategy as detailed below which aligns to the NHS 10 - year plan and the NHS cancer plan focussing on hospital to community shift and increased use of digital virtual patient support.
If you have any questions for team then please contact UKAOS on this link and we will forward the details.
Phase 1
We launched the pan-GM virtual daily AO MDT in November 2025 and all AO CNS teams in every acute hospital with an A&E across GM and Cheshire can list patients’ monday-friday for discussion +/- a virtual by the bed side review if required.
Economic evaluation and staff satisfaction of this MDT is currently underway supported by the NHS transformation unit.
For further information please look at the project document below
Phase 2
We have begun a process of engagement with every medical SDEC across GM and Cheshire and end of 2025 held a large stakeholder engagement session with 72 colleagues from primary, secondary and tertiary care, from clinical and managerial teams and from oncology and UEC services.
We asked the 3 questions below focussing around the 5 ambulatory AO conditions that UKOAS and Sam are co-publishing; UPE, febrile neutropenia, ambulatory MSCC, hypercalcaemia and new brain lesions
The answers were as follows
We have now started a process of education to enable all SDEC clinical staff to gain AO passport level 2 competencies supported by ensuring all AO CNSs across GM are level 3 competent (see photo 😊).
